FDA takes fast action to approve two new commercial COVID-19 diagnostic tests
The U.S. Food and Drug Administration on Monday granted emergency use authorization for two new commercial diagnostic tests, growing the number of tests available to four, in addition to tests from the Centers for Disease Control and Prevention and the New York State Department of Health.
|READ MORE >|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Wednesday, March 18, 2020
Subscribe to: Post Comments (Atom)
Post a Comment